North America Tissue Sectioning Market

Market Introduction

Tissue sectioning is a procedure that involves cutting tissues into thin sections so that they can be placed on a slide and then mounted under a microscope for study. It is used to examine tissue in order to detect any abnormalities or disease conditions. It is employed in histology laboratories, science laboratories, and other settings. Tissue processing is carried out after it has been examined between tissue embedding and fixation. Frozen sectioning and paraffin sectioning are the two types of tissue sectioning. It is used to detect breast nodules to determine whether a mastectomy is necessary, as well as to treat congenital megacolon in children and newborns. For advanced analysis, the tissues to be sectioned must be cut into very thin pieces or sections, i.e., 5-10 micrometer or smaller portions.

North America Tissue Sectioning Strategic Insights

Strategic insights for the North America Tissue Sectioning provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

North America Tissue Sectioning Report Scope

North America Tissue Sectioning Regional Insights

The geographic scope of the North America Tissue Sectioning refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

The North America tissue sectioning market is expected to reach US$ 352.32 million by 2028 from US$ 222.37 million in 2021. It is estimated to grow at a CAGR of 6.8% from 2021 to 2028. The increasing prevalence of chronic diseases and the rising adoption of personalized medicines are supporting the regional market. However, the lack of skilled professionals is expected to restrict the market growth during the forecast period.

Under the Ministry of Health and Family Welfare (MoHFW) and the Government of India, the NHM backed all states to provide essential diagnostics at their public health installations free of cost in India. Taking this initiative to global position, the WHO released the original edition of the Essential Diagnostics List (EDL) in May 2018. Fastening on the significance of diagnosis, the WHO stated the testing affects the majority of medical opinions. Appropriate diagnostic tests can inform evidence-based treatment and accountable use of medicines, performing in the overall bettered allocation of resources and better health outcomes.

With a remarkable rise in the aging population, several chronic ailments cases are showing an increase, leading to the necessity toward prevention and cure from a disorder, and, hence, the medical decision. Tissue sectioning (including necropsies, surgical or necropsy samples) is a core part of histopathological examinations, on which the physicians can blindly rely for the result accuracy. The superficial tissue sections may not represent the whole necropsy, which leads to repeated requests for deeper sections to enhance sensitivity and diagnostic delicacy. The data mentioned above and factors are performing in an increase in the number of remedial establishments. For illustration, pathology laboratories and clinics have increased the appropriation of tissue sectioning. These developments and rapid adoption are shifting the focus of pathologists and researchers toward exploring other approaches. Also, this massive contribution to ineffective treatments with the aid of histopathological examination is a significant factor in the growth of the tissue sectioning market. Due to an increasing number of infected patients, healthcare professionals and leading organizations in the US raised the demand for histopathological tests for severe Covid-19 incidents, encouraging the research and healthcare sector to focus actively on innovation.

North America is the leading market that has significantly contributed to the growth of the tissue sectioning market before the pandemic. Hence, the overall impact of Covid-19 on North America’s tissue sectioning market is positive. There have been various factors, including increased incidences of Covid-19 positive patients, growth in research, increasing production of vaccines, outcome study of the administered vaccine, and many other factors. For instance, the College of American Pathologists conducted research to report demographic and radiographic features in the lungs of patients infected and deceased with fatal Covid-19. All autopsies were performed at the College of American Pathologists. The study revealed that patients infected with Covid-19 have diffuse alveolar damage and commonly have acute bronchopneumonia and aspiration pneumonia. The cases led to the demand for diagnostic tests in the countries like the US, Canada, and Mexico. Thus, the tissue sectioning market in North America is positively impacted by Covid-19.

Key Market Segments

Based on the product, the North America tissue sectioning market is segmented into instruments, accessories & consumables, and services. The instruments segment is further sub-segmented into rotary microtome, ultramicrotome, cryostat, sliding microtome, and others. In 2021, the instruments segment held the largest market share. The accessories & consumables segment is expected to grow at the fastest CAGR during the forecast period.

Based on the technology, the North America tissue sectioning market is segmented into automatic, semiautomatic, and manual. The automatic technology segment led the largest share of the market in 2021 and is estimated to register the highest CAGR in the market during the forecast period.

Based on application, the North America tissue sectioning market is segmented into diagnosis and research. In 2021, the diagnosis segment accounted for the largest share of the market. The research segment is expected to witness the fastest CAGR from 2021 to 2028.

The North America tissue sectioning market is segmented into hospitals, clinics, diagnostic laboratories, digital path labs, and others based on the end user. In 2021, the hospitals segment led the tissue sectioning market. However, the diagnostic laboratories segment is expected to report the fastest CAGR from 2021 to 2028.

Major Sources and Companies Listed

A few of the primary and secondary sources associated with this report on the North America tissue sectioning market are the Center for Disease Control and Prevention (CDC), Pharmaceutical Research and Manufacturers Association (PhRMA), and the United States Pharmacopeia (USP).

Reasons to buy the report

• Determine prospective investment areas based on a detailed trend analysis of North America tissue sectioning market over the next years.
• Gain an in-depth understanding of the underlying factors driving demand for different addictions therapeutics segments in the top spending countries and identify the opportunities offered by each of them.
• Strengthen your knowledge of the market in terms of demand drivers, industry trends, and the latest technological developments, among others.
• Identify the major channels driving the North America tissue sectioning market, providing a clear picture of future opportunities that will help analyze, resulting in revenue expansion.
• Channelize resources by focusing on the ongoing programs undertaken by the different countries within the North America tissue sectioning market.

NORTH AMERICA TISSUE SECTIONING MARKET SEGMENTATION

By

Product

• Instruments

• • Rotary Microtome
  • Ultramicrotome
  • Cryostat
  • Sliding Microtome
  • Others
• Accessories and Consumables

• Services

By

Technology

• Automatic
• Semi-Automatic
• Manual

By Application

• Diagnosis
• Research

By End User

•   Hospitals

•   Clinics

•   Diagnostic Laboratories

•   Digital Path Labs

• Others

By Country

• U.S
• Canada
• Mexico

Company Profiles

• THERMO FISHER SCIENTIFIC, INC.
• Leica Biosystems Nussloch GmbH (Danaher)
• Diapath S.p.A
• MEDITE Medical GmbH
• Abcam Plc